Form 4: Arteris Director Joachim Kunkel Receives RSU Grant

Director Joachim Kunkel was granted 4,703 restricted stock units as part of his compensation for service to Arteris, Inc.

Summary

• Director Joachim Kunkel acquired 4,703 restricted stock units (RSUs) on June 2, 2026.
• The grant represents a contingent right to receive one share of common stock per unit.
• The RSU grant was valued based on an average trading price of $31.89 per share.
• Following this transaction, the director's total beneficial ownership stands at 74,330 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation with no material impact on company operations.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• Dilutive impact of new equity grants to board members.

Risks

• Vesting is contingent upon the director continuing to provide services to the Board through the vesting date.

Future Outlook

The RSUs will vest in full on the earlier of the first anniversary of the grant date or immediately before the next annual meeting of stockholders.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice in the technology sector to ensure long-term alignment with shareholder value.

Comparison to Industry Standards

• The use of RSUs for director compensation is consistent with standard practices for publicly traded technology companies.
• Vesting schedules tied to annual meetings are common among mid-cap technology firms.

Stakeholder Impact

• Minor dilution for existing shareholders due to the issuance of new equity.

Next Steps

• Vesting of 4,703 RSUs on the earlier of June 2, 2027, or the date of the next annual stockholders meeting.

Key Dates

Keywords

Arteris, AIP, Form 4, Insider Trading, Director Compensation, Restricted Stock Units